A Small Conserved Surface in SUMO Is the Critical Structural Determinant of Its Transcriptional Inhibitory Properties

ABSTRACT Small ubiquitin-like modifier (SUMO) modification of sequence-specific transcription factors has profound regulatory consequences. By providing an intrinsic inhibitory function, SUMO isoforms can suppress transcriptional activation, particularly at promoters harboring multiple response elements. Through a comprehensive structure-function analysis, we have identified a single critical sector along the second beta sheet and the following alpha helix of SUMO2. This distinct surface is defined by four basic residues (K33, K35, K42, R50) that surround a shallow pocket lined by aliphatic (V30, I34) and polar (T38) residues. Substitutions within this area specifically and dramatically affected the ability of both SUMO2 and SUMO1 to inhibit transcription and revealed that the positively charged nature of the key basic residues is the main feature responsible for their functional role. This highly conserved surface accounts for the inhibitory properties of SUMO on multiple transcription factors and promoter contexts and likely defines the interaction surface for the corepressors that mediate the inhibitory properties of SUMO.

[1]  T. A. Wilkinson,et al.  Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Wen-Chen Huang,et al.  Crystal structures of the human SUMO-2 protein at 1.6 A and 1.2 A resolution: implication on the functional differences of SUMO proteins. , 2004, European journal of biochemistry.

[3]  David Reverter,et al.  A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. , 2004, Structure.

[4]  J. She,et al.  A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes , 2004, Nature Genetics.

[5]  K. Bohren,et al.  A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.

[6]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[7]  David W. Miller,et al.  A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8 , 2004, Nature Structural &Molecular Biology.

[8]  Scott D Emr,et al.  Ubiquitin interactions of NZF zinc fingers , 2004, The EMBO journal.

[9]  F. Z. Watts.  SUMO modification of proteins other than transcription factors. , 2004, Seminars in cell & developmental biology.

[10]  W. Sundquist,et al.  Ubiquitin recognition by the human TSG101 protein. , 2004, Molecular cell.

[11]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[12]  Peter O'Hare,et al.  Characterization of the Localization and Proteolytic Activity of the SUMO-specific Protease, SENP1* , 2004, Journal of Biological Chemistry.

[13]  J. Iñiguez-Lluhí,et al.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Linda Hicke,et al.  Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. , 2003, Annual review of cell and developmental biology.

[15]  R. Eisenman,et al.  Histone sumoylation is associated with transcriptional repression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Linda Hicke,et al.  Solution structure of Vps27 UIM–ubiquitin complex important for endosomal sorting and receptor downregulation , 2003, The EMBO journal.

[17]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[18]  K. Nakao,et al.  Modification of GATA‐2 Transcriptional Activity in Endothelial Cells by the SUMO E3 Ligase PIASy , 2003, Circulation research.

[19]  W. Salerno,et al.  Solution Structure of a CUE-Ubiquitin Complex Reveals a Conserved Mode of Ubiquitin Binding , 2003, Cell.

[20]  Keiji Tanaka,et al.  Sterol Regulatory Element-binding Proteins Are Negatively Regulated through SUMO-1 Modification Independent of the Ubiquitin/26 S Proteasome Pathway* , 2003, The Journal of Biological Chemistry.

[21]  F. Melchior,et al.  Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. , 2003, Molecular cell.

[22]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[23]  L. Hood,et al.  Regulatory gene networks and the properties of the developmental process , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[25]  H. Yasuda,et al.  PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Repress Androgen Receptor-dependent Transcription* , 2002, The Journal of Biological Chemistry.

[26]  O. Jänne,et al.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. , 2002, The Biochemical journal.

[27]  Peter F. Johnson,et al.  Transcriptional Activity of CCAAT/Enhancer-binding Proteins Is Controlled by a Conserved Inhibitory Domain That Is a Target for Sumoylation* , 2002, The Journal of Biological Chemistry.

[28]  F. Melchior,et al.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1 , 2002, The EMBO journal.

[29]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[30]  K. Horwitz,et al.  The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression* , 2002, The Journal of Biological Chemistry.

[31]  H. Su,et al.  Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. , 2002, Gene.

[32]  O. Jänne,et al.  The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1* , 2002, The Journal of Biological Chemistry.

[33]  R. DePinho,et al.  SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.

[34]  E. Miska,et al.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.

[35]  M. Dasso,et al.  Association of the Human SUMO-1 Protease SENP2 with the Nuclear Pore* , 2002, The Journal of Biological Chemistry.

[36]  J. Markus,et al.  Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity* , 2002, The Journal of Biological Chemistry.

[37]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Dejean,et al.  The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.

[39]  M. Tatham,et al.  Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9* , 2001, The Journal of Biological Chemistry.

[40]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[41]  C. Pickart,et al.  Distinct Functional Surface Regions on Ubiquitin* , 2001, The Journal of Biological Chemistry.

[42]  A Miyawaki,et al.  Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis. , 2000, Nucleic acids research.

[43]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[44]  S. H. Baek,et al.  A New SUMO-1-specific Protease, SUSP1, That Is Highly Expressed in Reproductive Organs* , 2000, The Journal of Biological Chemistry.

[45]  C. Lima,et al.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. , 2000, Molecular cell.

[46]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[47]  H. Saitoh,et al.  Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.

[48]  David J. Chen,et al.  The Binding Interface between an E2 (UBC9) and a Ubiquitin Homologue (UBL1)* , 1999, The Journal of Biological Chemistry.

[49]  E. Yeh,et al.  Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin‐activating enzyme complex , 1999, FEBS letters.

[50]  Werner Braun,et al.  Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..

[51]  M. Carey,et al.  The Enhanceosome and Transcriptional Synergy , 1998, Cell.

[52]  R. Hay,et al.  Ubch9 conjugates SUMO but not ubiquitin , 1997, FEBS letters.

[53]  Tal Pupko,et al.  Structural Genomics , 2005 .

[54]  K. Yamamoto,et al.  Building transcriptional regulatory complexes: signals and surfaces. , 1998, Cold Spring Harbor symposia on quantitative biology.

[55]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.